Humana Inc.
HUM
Rank in Stocks
#487
Humana Inc., a prominent health and well-being enterprise, operates across the... Humana Inc., a prominent health and well-being enterprise, operates across the United States through its various subsidiary companies. Its operational structure is divided into three main segments: Retail, Group and Specialty, and Healthcare Services. The firm provides a wide array of medical and supplementary insurance plans directly to individual consumers. Furthermore, Humana collaborates with government entities; it holds a contract with the Centers for Medicare and Medicaid Services (CMS) to manage the Limited Income Newly Eligible Transition (LI NET) prescription drug program. The company also secures agreements with numerous states to deliver Medicaid, dual-eligible, and long-term care support benefits. For employer groups and individuals, Humana furnishes fully insured commercial medical and specialized health coverage, which encompasses dental, vision, and other ancillary health benefits. They additionally offer administrative services only (ASO) solutions and extend support to military personnel through contracts like the TRICARE T2017 East Region. Beyond insurance products, the company delivers comprehensive healthcare services directly. These include pharmacy management, provider network services, and a suite of home-based solutions such as home health care, serving both its own health plan enrollees and external clients. By the close of 2021 (December 31), Humana's reach extended to approximately 17 million individuals enrolled in its medical benefit plans and an additional 5 million utilizing its specialized product offerings. Established in 1961, Humana Inc. maintains its corporate headquarters in Louisville, Kentucky.
Share Price
$412.79
Market Cap
$49.57B
Change (1 day)
-0.26%
Change (1 year)
50.10%
Country
US
Trade Humana Inc. (HUM)
Category
Healthcare
P/E ratio for Humana Inc. (HUM)
P/E ratio as of October 2026 TTM: 40.15
According to Humana Inc. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 40.15. At the end of 2023 the company had a P/E ratio of 22.78.
P/E ratio history for Humana Inc. from 2000 to 2026
P/E ratio at the end of each year
| Year | P/E Ratio | Change |
|---|---|---|
| 2026 (TTM) | 40.15 | 58.44% |
| 2024 | 25.34 | 11.24% |
| 2023 | 22.78 | -1.27% |
| 2022 | 23.08 | 13.38% |
| 2021 | 20.35 | 26.35% |
| 2020 | 16.11 | -11.25% |
| 2019 | 18.15 | -22.44% |
| 2018 | 23.40 | 59.83% |
| 2017 | 14.64 | -70.50% |
| 2016 | 49.64 | 137.40% |
| 2015 | 20.91 | 8.29% |
| 2014 | 19.31 | 46.20% |
| 2013 | 13.21 | 45.62% |
| 2012 | 9.07 | -11.20% |
| 2011 | 10.21 | 22.21% |
| 2010 | 8.36 | 18.28% |
| 2009 | 7.07 | -26.63% |
| 2008 | 9.63 | -36.11% |
| 2007 | 15.07 | -19.06% |
| 2006 | 18.62 | -34.53% |
| 2005 | 28.45 | 67.66% |
| 2004 | 16.97 | 4.69% |
| 2003 | 16.21 | 37.75% |
| 2002 | 11.76 | -29.15% |
| 2001 | 16.61 | -41.20% |
| 2000 | 28.24 | 0.00% |
P/E ratio for similar companies or competitors
| Company | P/E Ratio | P/E Ratio Difference | Country |
|---|---|---|---|
| 22.58 | -43.76% |
US
|
|
| 23.60 | -41.22% |
US
|
|
| 19.03 | -52.61% |
US
|
|
| 11.94 | -70.26% |
US
|
|
| - | - |
US
|
How to read a P/E ratio?
The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.
Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.
Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.